CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 140 filers reported holding CARDLYTICS INC in Q2 2022. The put-call ratio across all filers is 0.95 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $264 | +151.4% | 15,977 | -48.2% | 0.00% | +200.0% |
| Q1 2023 | $105 | -41.0% | 30,821 | +0.3% | 0.00% | -50.0% |
| Q4 2022 | $178 | -99.9% | 30,716 | +55.9% | 0.00% | 0.0% |
| Q3 2022 | $185,000 | -88.0% | 19,700 | -71.4% | 0.00% | -87.5% |
| Q2 2022 | $1,536,000 | +49.9% | 68,839 | +269.2% | 0.02% | +100.0% |
| Q1 2022 | $1,025,000 | +7.7% | 18,647 | +29.5% | 0.01% | +60.0% |
| Q4 2021 | $952,000 | -3.8% | 14,398 | +22.1% | 0.01% | 0.0% |
| Q3 2021 | $990,000 | +465.7% | 11,796 | +757.9% | 0.01% | +400.0% |
| Q2 2021 | $175,000 | -67.8% | 1,375 | -72.3% | 0.00% | -66.7% |
| Q1 2021 | $544,000 | +113.3% | 4,961 | +178.1% | 0.00% | +200.0% |
| Q4 2020 | $255,000 | +44.9% | 1,784 | -29.1% | 0.00% | 0.0% |
| Q2 2020 | $176,000 | +60.0% | 2,515 | +43.2% | 0.00% | 0.0% |
| Q4 2019 | $110,000 | -89.2% | 1,756 | -97.1% | 0.00% | -88.9% |
| Q1 2019 | $1,014,000 | +56.5% | 61,277 | +2.3% | 0.01% | +50.0% |
| Q4 2018 | $648,000 | -56.8% | 59,875 | -0.1% | 0.01% | -45.5% |
| Q3 2018 | $1,501,000 | – | 59,950 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAS Investment Partners, LLC | 4,488,972 | $640,891,000 | 35.51% |
| Antipodean Advisors LLC | 656,000 | $93,657,000 | 26.30% |
| KPS Global Asset Management UK Ltd | 1,021,830 | $145,887,000 | 21.39% |
| BRIGHTLIGHT CAPITAL MANAGEMENT LP | 302,700 | $43,216,000 | 17.58% |
| Oakcliff Capital Partners, LP | 269,895 | $38,533,000 | 15.30% |
| Alua Capital Management LP | 920,259 | $131,385,000 | 9.19% |
| Covey Capital Advisors, LLC | 47,736 | $6,815,000 | 5.95% |
| EVR Research LP | 50,000 | $7,139,000 | 5.83% |
| 683 Capital Management, LLC | 659,997 | $94,228,000 | 4.46% |
| Hidden Lake Asset Management LP | 72,900 | $10,408,000 | 4.08% |